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We previously showed that a local immune response largely
composed of type 1 T cells correlated with a favorable
outcome of the peritonitis associated with peritoneal dialysis.
To clarify how these subsets are recruited to the peritoneal
cavity during inflammation, we measured integrin-mediated
interactions between the T cells and human peritoneal
mesothelial cells. Direct microscopy showed that
lipopolysaccharide or peritoneal dialysis effluent stimulated
the adherence of T cells to mesothelial cells, a process
mediated by the integrins a6b1 and a4b1. Further, the
migration of Th1 cell across human mesothelial cell
monolayers grown on transwell surfaces was reduced by
anti-a6b1 integrin antibody while that of Th2 cell was
inhibited by an anti-a4 integrin antibody. Pretreatment with
either lipopolysaccharide or rapid response peritoneal
dialysis effluent stimulated T cell migration and this was
significantly decreased by the a6b1 compared to the a4
antibody. These results suggest that integrins may play an
important role in mediating selective T cell subset adhesion
and migration across human peritoneal mesothelial cell
monolayers and differential integrin expression and selective
T cell subset recruitment during peritonitis may affect
outcome.
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Peritoneal dialysis (PD) is an established treatment for end-
stage renal disease.1 Peritonitis, a local inflammatory
disorder, is the most serious complication of PD.2–7 All the
resident peritoneal cavity cells, as well as the leukocytes that
are recruited and infiltrate, coordinate the immune response
associated with peritoneal infection.8–10
Human peritoneal mesothelial cells (HPMCs) line the
surface of the peritoneal membrane. Following stimulation
by bacteria-secreted products or pro-inflammatory cytokines,
HPMCs secrete inflammatory cytokines and chemokines,
which activate and control peritoneal inflammatory processes
and attract leukocytes into the peritoneal cavity.11–15 HPMCs
constitutively express intracellular adhesion molecule-1 and
vascular cell adhesion molecule-1; expressions of both are
increased with in vivo inflammation or after cytokine
stimulation in vitro.11,16–19 Thus, HPMCs play an important
role in mediating leukocyte trafficking into the peritoneal
cavity.
In PD patients, leukocyte infiltration into the peritoneal
cavity is important for eradicating the invading organ-
isms.20,21 The mechanisms that control leukocyte extravasa-
tion from the circulation have been extensively studied.
However, how leukocytes recognize and traverse the perito-
neal mesothelial lining and enter the peritoneal cavity has
yet to be determined. Previous investigations have addressed
the role of intracellular adhesion molecule-1 expression in
leukocyte migration across HPMCs,11,16,22 and the role of
interferon-g and interleukin (IL)-17 in controlling neutrophil
migration across the mesothelium.23,24 The mechanisms that
control T-lymphocyte migration across HPMCs have not
been addressed.
The T-cell/subsets response plays a role in peritoneal
immunity during peritonitis. Previous studies showed that
interferon-g levels in PD effluent (PDE) were often elevated
in patients with bacterial peritonitis.25 We previously found
that a progressive increase in the CD4/CD8 ratio in PDE
indicated a favorable outcome in patients with PD-related
peritonitis.26 We recently found that high IL-12 and IL-18
levels in PDE during the early phase of peritonitis were
correlated with a predominant type I T-cell immune response
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and a favorable outcome.27 Some studies show the link
between T cells and HPMCs in peritoneal immunity.
Hausmann et al.28 found that HPMCs participated in the
peritoneal immune response by antigen presentation and
contributed to T-cell activation by secreting IL-15.28 Basok
et al.29 reported that CD40, whose ligand is mainly expressed
on the membrane of activated CD4 lymphocytes, is expressed
on HPMCs. However, the interaction between T cells and
HPMCs needs further study.
Integrins mediate cell–cell and cell–extracellular matrix
adhesion.30–33 Integrins are not simply adhesion sites on
T cells; they play prominent roles in the migration of T cells
to peripheral lymph node and inflammatory sites, in antigen
presentation, cytotoxic killing, and transduction of co-stimula-
tory signals in T cells.34–38 T helper (Th) subtype 1 (Th1) and
subtype 2 (Th2) cells have different integrin expression patterns;
these differences contribute to the differential recruitment of
Th1 and Th2 cells39 and promote a predominant type I or type
II T-cell immune response. Previous studies showed preferential
expression of integrin a6b1 on Th1 cells; IL-12 upregulates their
expression and promotes Th1 cell migration.39–41 Th2 cells
express elevated levels of a4b1 integrins, which mediate Th2 cell
adhesion and migration.35,39,41,42 The role of T-cell integrin
as an adhesion, migration, and co-stimulatory molecule
suggests that integrins may be involved in the interaction
between T cells and HPMCs. However, the role and
regulation of T-cell integrins during the interaction with
HPMCs are poorly defined.
To clarify the mechanisms of T-lymphocyte adherence and
migration across HPMCs, we developed an in vitro adhesion
and migration assay to determine whether integrins are
involved in T lymphocyte–mesothelial recognition under
various conditions. The various integrins involved in the
different T-cell subsets and in their interaction with HPMCs
were also investigated to elucidate the mechanism regulating
the polarized T-cell immune response. Our data indicate
that integrins may play an important role in mediating
T-lymphocyte adhesion and migration across HPMCs; the
presence of differential integrins promotes the selective
recruitment of T-cell subsets and correlates with peritonitis
treatment outcome.
RESULTS
Adherence of T lymphocytes to HPMCs
To determine whether T lymphocytes are capable of adhering
to HPMCs under different environmental stimuli, the
adhesion relationships were observed directly under a
microscope. HPMCs have a small, round, often eccentric,
nucleus and a large amount of cytoplasm (Figure 1a). When
HPMCs were not pre-stimulated, 3.0±1.6% of HPMC–T-
lymphocytes formed rosettes (Figure 1b). When HPMCs
were pre-exposed to lipopolysaccharide (LPS), 20.2±3.1%
formed rosettes (Figure 1c). When HPMCs were pre-exposed
to rapid and delayed-response PDE, 19.1±2.9% (Figure 1d)
and 18.2±3.3% (Figure 1e) formed rosettes, respectively.
After stimulation with LPS or PDE, HPMCs showed a
polarized morphology with multiple elongated cytoplasmic
processes (Figure 1c–e). Compared with HPMCs without
pre-stimulation, significantly more LPS- and PDE-pretreated
HPMCs formed rosettes with T lymphocytes (Po0.05).
These data show that T lymphocytes exhibit low-level specific
binding to HPMCs under control conditions, and that
stimulation enhances adhesion.
Integrin expression during HPMC–T-lymphocyte adhesion
To study integrin expression during HPMC–T-lymphocyte
adhesion, immunofluorescence staining was carried out. The
expression of a6b1 and a4b1 integrins was examined due to
a b c
d e
Figure 1 | Adhesion between T lymphocytes and HPMCs. (a) The morphology of unstimulated HPMCs. HPMC–T-lymphocyte rosette
formation was seen in (b) 3.0±1.6% when the HPMCs were not pre-stimulated; (c) 20.2±3.1% when HPMCs were pre-stimulated with LPS
10mg/ml; (d) 19.1±2.9% when HPMCs were pre-stimulated with rapid-response PDE 1000 mg/ml; and (e) 18.2±3.3% when HPMCs were
pre-stimulated with delayed-response PDE 1000 mg/ml.
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their potential role in Th subset adhesion and migration.
When T lymphocytes interacted with unstimulated HPMCs,
the expressions of integrins a6b1 and a4b1 were 4.7±1.1%
and 3.2±0.7%, respectively (Figure 2a). When HPMCs were
pre-stimulated with LPS, the T-lymphocyte expressions of
integrins a6b1 and a4b1 increased to 36.4±5.3% and
32.2±4.3%, respectively (Figure 2b). Compared with
the control group of HPMCs without pre-stimulation,
T-lymphocyte expressions of integrins a6b1 and a4b1 increa-
sed significantly (Po0.05). When HPMCs were pre-stimu-
lated with rapid-response PDE, T-lymphocyte expressions of
a6b1 and a4b1 integrins increased significantly (Po0.05)
compared with the control groups (38.6±4.4%, 35.9±5.3%,
respectively; Figure 2c). T-lymphocyte expressions of a6b1
(35.2±4.2%) and a4b1 (36.4±3.7%) integrins increased
significantly (Po0.05) when they interacted with HPMCs
pretreated with delayed-response PDE (Figure 2d), compared
with when they interacted with unstimulated HPMC
controls. Blank controls with HPMC only were negative for
the expression of both a6b1 and a4b1 integrins. Thus,
integrins a6b1 and a4b1 are involved in HPMC–T-lympho-
cyte adhesion, and their expression increases after HPMC
pre-stimulation.
T-lymphocyte migration across HPMCs and the effect
of LPS and PDE
To determine whether T lymphocytes migrate across HPMCs
under various environmental stimuli, an in vitro migration
system was used to assess the time course of changes (Figure 3).
Apical pre-stimulation of the HPMC monolayer with LPS or
PDE resulted in a time-dependent increase in T-lymphocyte
migration across HPMCs. T-lymphocyte migration across pre-
stimulated HPMCs was significantly greater than control after
2 h of stimulation, and continued to increase (Po0.05;
Figure 3). No significant difference in T-lymphocyte migration
was observed for HPMCs pre-stimulated with LPS or PDE
(rapid or delayed clinical response).
Integrins mediate T-lymphocyte migration across HPMCs
To determine whether integrins had an effect on
T-lymphocyte migration across HPMCs, antibody-blocking
of T-lymphocyte migration was studied. In the control group,
T-lymphocyte migration was not significantly reduced by
pretreatment with anti-a6b1 or anti-a4 antibody (Figure 4a).
T lymphocytes pretreated with anti-a6b1 or anti-a4 anti-
body had significantly reduced migration across HPMCs
in the LPS and PDE groups (Figure 4b–d). When HPMCs
were pre-stimulated with LPS, T lymphocytes pretreated with
anti-a6b1 antibody showed significantly reduced migration
Figure 2 | Immunofluorescence staining of integrin expression during HPMC–T-lymphocyte adhesion. (a) T lymphocytes adhered to
unstimulated HPMCs. Upper panel: 4.7±1.1% of T lymphocytes were stained with anti-a6b1 antibody and showed green fluorescence.
Lower panel: 3.2±0.7% of T lymphocytes were stained with anti-a4 antibody and showed red fluorescence. (b) T lymphocytes adhered
to HPMC pre-stimulated with LPS 10 mg/ml. Upper panel: 36.4±5.3% of T lymphocytes were stained with anti-a6b1 antibody and
showed green fluorescence. Lower panel: 32.2±4.3% of T lymphocytes were stained with anti-a4 antibody and showed red fluorescence.
(c) T lymphocytes adhered to HPMCs pre-stimulated with rapid-response PDE 1000 mg/ml. Upper panel: 38.6±4.4% of T lymphocytes
were stained with anti-a6b1 antibody and showed green fluorescence. Lower panel: 35.9±5.3% of T lymphocytes were stained with
anti-a4 antibody and showed red fluorescence. (d) T lymphocytes adhered to HPMCs pre-stimulated with delayed-response PDE
1000 mg/ml. Upper panel: 35.2±4.2% of T lymphocytes were stained with anti-a6b1 antibody and showed green fluorescence.
Lower panel: 36.4±3.7% of T lymphocytes were stained with anti-a4 antibody and showed red fluorescence.
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Figure 3 | Effect of HPMC pre-stimulation on T-lymphocyte
migration. Apical pre-stimulation of the HPMC monolayer with
LPS or PDE resulted in a time-dependent increase in the migration
of T lymphocytes across HPMC. K, control; J LPS 10 mg/ml;
. rapid-response PDE 1000 mg/ml; , delayed-response PDE
1000 mg/ml. Data are expressed as mean±s.d. from eight separate
experiments. *Po0.05 versus control.
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after 6 h stimulation and continued throughout the entire
duration of the study, compared to T lymphocytes pretreated
with anti-a4 antibody (Po0.05; Figure 4b). Similar results
were noted in HPMCs pre-stimulated with rapid-response
PDE (Figure 4c). However, when HPMCs were pre-
stimulated with delayed-response PDE, the reduction in
T-lymphocyte migration was similar to that seen with
anti-a6b1 and anti-a4 antibody pretreatment (P40.05;
Figure 4d). These data suggest that integrins play a role
in T-lymphocyte migration across HPMCs. However, the
importance of a6b1 and a4b1 integrins depends on the
conditions used to stimulate HPMCs.
Migration of Th1 cells across HPMCs is primarily mediated
by a6b1 integrin
Polarized human Th lymphocytes were generated (Figure 5)
to study how different integrins mediate the migration of the
various T-cell subsets across HPMCs. In the control group,
there was no significant reduction of Th1-cell migra-
tion following anti-a6b1 or anti-a4 antibody treatment
(Figure 6a). In the LPS and PDE groups, Th1 cells that were
pretreated with anti-a6b1 antibody showed decreased
migration across HPMCs compared with untreated Th1 cells
(Figure 6b–d). When Th1 cells were pretreated with anti-a4
antibody, Th1-cell migration was mildly decreased compared
with untreated Th1 cells, but the difference was not
statistically significant (Figure 6b–d). In the LPS- and PDE-
stimulated groups, there was a significant decrease in Th1-cell
migration with anti-a6b1 antibody treatment compared with
anti-a4 antibody treatment throughout the experiment
(Po0.05; Figure 6b–d). These data suggest that a6b1 integrin
is more important than a4b1 integrin in Th1-cell migration
across HPMCs.
Migration of Th2 cells across HPMCs is primarily mediated
by a4b1 integrin
In the control group, there was no significant reduction in
Th2-cell migration after pretreatment with either anti-a6b1 or
anti-a4 antibody (Figure 7a). In the LPS- and PDE-stimulated
groups, pretreatment with anti-a4 antibody inhibited Th2-cell
migration across HPMCs compared with untreated Th2 cells
(Po0.05; Figure 7b–d). The reduction in Th2-cell migration
occurred after 2 h of stimulation and continued throughout
the entire experiment. Th2-cell migration was somewhat
reduced with anti-a6b1 antibody pretreatment, but, compared
with untreated Th2 cells, the difference was not statistically
significant (Figure 7b–d). In the LPS- and PDE-stimulated
groups, there was a significant decrease in Th2-cell migration
with anti-a4 antibody treatment compared with anti-a6b1
antibody treatment (Po0.05; Figure 7b–d). Thus, a4b1
integrin appears to be more important than a6b1 integrin in
Th2-cell migration across HPMCs.
DISCUSSION
The present study used in vitro systems to examine the
adhesion relationship and migration behavior of HPMCs and
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Figure 4 | Inhibition of T-lymphocyte migration across HPMCs by anti-integrin antibodies. (a) HPMCs without pre-stimulation at
different time periods; HPMCs pre-stimulated with (b) LPS 10mg/ml; (c) rapid-response PDE 1000mg/ml; (d) delayed-response PDE 1000mg/ml
in different time periods.’, no antibody; , T lymphocytes pretreated with anti-a6b1 antibody; , T lymphocytes pretreated with anti-a4
antibody; &, T lymphocytes pretreated with isotype-matched control antibody. Data are expressed as mean±s.d. from eight separate
experiments. *Po0.05 versus control, **Po0.05 anti-a6b1 antibody versus anti-a4 antibody.
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T lymphocytes. The morphology of the T-lymphocyte–
mesothelial cell interaction and the role that integrins play
in the interaction have not been previously reported with
respect to peritoneal immunity.
Microscopic observation showed direct adhesion of
HPMCs and T lymphocytes through rosette formation.
This provides evidence that the mesothelium plays an active
role in peritoneal inflammatory processes. Based on
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Figure 5 | Flow cytometry analyses of Th1 and Th2 cells phenotypes generated in vitro. The phenotype of the in vitro differentiated
Th1 and Th2 cells was determined by two-color intracytoplasmic staining for interferon (IFN)-g and IL-4-producing cells. The fraction of
cells located in each quadrant is indicated in the inset. One representative experiment of the eight that were done is shown.
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Figure 6 | Inhibition of Th1-cell migration across HPMCs by anti-a6b1 antibodies. (a) HPMCs without pre-stimulation at different time
periods; HPMCs pre-stimulated with (b) LPS 10 mg/ml; (c) rapid-response PDE 1000 mg/ml; (d) delayed-response PDE 1000 mg/ml in different
time periods. ’, no antibody; , Th1 cells pretreated with anti-a6b1 antibody; , Th1 cells pretreated with anti-a4 antibody; &, Th1 cells
pretreated with isotype-matched control antibody. Data are expressed as mean±s.d. from eight separate experiments. *Po0.05 versus
control, **Po0.05 anti-a6b1 antibody versus anti-a4 antibody.
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immunofluorescence staining, it was found that integrins
a6b1 and a4b1 were involved in the interaction and that
their expression increased after stimulation. The data suggest
that both integrin and its ligand are important in peritoneal
inflammatory and immune reaction. The present study also
found morphological evidence that HPMCs may act as
antigen-presenting cells,28 and that integrins may act as co-
stimulatory molecules that activate T lymphocytes and
promote the adaptive peritoneal immune response.
The migration assay study indicated the importance
of integrins a6b1 and a4b1 in the migration process of
T lymphocytes across HPMCs. Furthermore, a6b1 integrin
predominantly mediates Th1-cell migration across HPMCs
and a4b1 integrin predominantly mediates Th2-cell migra-
tion. To the best of our knowledge, this is the first time that
Th-subset integrin expression and function have been
demonstrated in peritonitis. The differential expression of
integrins on Th subsets is compatible with previous studies
under other conditions.35,39–42 These data suggest that
integrins are expressed on T lymphocytes and play an
important regulatory role in controlling the phenotype of
infiltrating T lymphocytes during peritoneal inflammation.
In our previous study,27 a type I T-cell response was found
to be critical for favorable outcome following peritonitis
treatment. In the present study, stimulation with rapid-
response PDE caused a profound decrease in T-cell migration
when the T cells were pretreated with anti-a6b1 antibody.
These data indicate that, with rapid-response PDE stimula-
tion, adaptive immunity predominantly shifted toward Th1
immune response, which is clinically correlated with a
favorable treatment outcome. The maintenance of a func-
tionally polarized immune response requires different T-cell
subsets to localize in sites of inflammation. The present data
may explain how different T-cell subsets are preferentially
recruited to sites of peritoneal inflammation; selective
modulation of these integrins illustrates an additional level
of control for specific T-cell subset homing. Manipulating
T-lymphocyte integrin expression could modulate the Th1/Th2
balance and affect the outcome of peritonitis treatment.
The present study shows that under LPS stimulation, a
Th1 immune response was predominant; T-lymphocyte
migration was significantly decreased with anti-a6b1 anti-
body pretreatment compared with anti-a4 antibody pre-
treatment. In previous studies, LPS from Escherichia coli was
found to induce a Th1 response,43,44 whereas LPS from
Porphyromonas gingivalis and schistosome egg antigen
induced Th2 responses.43,45,46 The present data are consistent
with previous studies,43,44,47–52 showing that LPS induces Th1
polarization. Toll-like receptor 4 principally recognizes LPS
and mediates LPS transduction. Kato et al.53 found that Toll-
like receptor 4 induces chemokine expression in murine
peritoneal mesothelial cells; this may play a role in inducing
peritoneal inflammation and fibrosis. Further studies to
delineate the interaction of Toll-like receptor 4 in HPMCs
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Figure 7 | Inhibition of Th2-cell migration across HPMCs by anti-a4 antibodies. (a) HPMCs without pre-stimulation at different time
periods; HPMC pre-stimulated with (b) LPS 10 mg/ml; (c) rapid-response PDE 1000 mg/ml; (d) delayed-response PDE 1000 mg/ml in different
time periods. ’, no antibody; , Th2 cells pretreated with anti-a6b1 antibody; , Th2 cells pretreated with anti-a4 antibody; &, Th2 cells
pretreated with isotype-matched control antibody. Data are expressed as mean±s.d. from eight separate experiments. *Po0.05 versus
control, **Po0.05 anti-a6b1 antibody versus anti-a4 antibody.
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and LPS, which results in various levels of a6b1 expression by
peritoneal T cells, will provide new insights into how
peritoneal inflammation and, possibly, even fibrosis are
modulated.
Environmental stimuli are important for HPMC–T-
lymphocyte interaction. Our results show that exposure to
bacterial products or PDE modulates the adhesion and
migration properties of T-lymphocytes. This phenomenon is
compatible with the characteristics of integrins. Under
normal conditions, integrins are inactive. Integrins provide
strong adhesion and migration only after activation by other
stimuli, such as exposure to cytokines or chemokines; the
engagement of other cell-surface receptors results in rapid
integrin activation and ligand binding.30,34 The strength with
which integrins bind to their ligands can be rapidly and
precisely regulated; this is called ‘affinity modulation’.54 Our
data support the findings that T-cell integrins play important
roles in the interaction between HPMC and T cell only in the
presence of environmental stimuli.
As the integrin antibody-blocking experiments did not
show complete inhibition in this in vitro migration assay, it is
likely that some other molecules may also be involved in
T-lymphocyte migration across HPMCs. Although the
concentration of these other molecules appears to be less
than that of integrins, these other adhesion molecules should
be identified. Combined with our current results, additional
studies delineating other adhesion molecules involved in
T-lymphocyte migration across HPMCs will enhance our
understanding of the T-lymphocyte-trafficking mechanism
during peritoneal inflammation.
In conclusion, the present study found that integrins
play an important role in T-lymphocyte adherence and
migration across HPMCs, which are important in regulating
the traffic of T lymphocytes into the peritoneal cavity.
Different T-cell subsets express different integrins; this
may mediate the polarized Th1/Th2 immune reaction in
peritonitis. Th-subset recruitment and the outcome of
peritonitis could be affected by manipulating the expression
of different integrins or by blocking the function of different
integrins. These findings enhance our understanding of
the peritoneal immune response and facilitate the develop-
ment of new strategies for peritonitis immunotherapy and
prevention.
METHODS
Peritonitis and response to treatment
The definitions related to peritonitis and response to treatment were
as previously described.27 A rapid clinical response was defined as
the resolution of the symptoms of peritonitis, including disappear-
ance of abdominal pain and clearing of the peritoneal dialysate
within 72 h of the initiation of antibiotic therapy, followed by
complete recovery within 7–10 days of treatment initiation.
A delayed clinical response refractory to treatment was defined as
the persistence of symptoms, positive dialysate cultures, and an
elevated white blood cell count in the dialysate beyond 72 h after the
initiation of appropriate antibiotic treatment, followed by a
fluctuating and protracted course lasting X10–14 days.
PDE collection
On day 0, after the onset of symptoms and prior to antibiotic
treatment, bags of PDE were collected and sent to the research
lab. The PDE was centrifuged at 400 g, 41C for 10 min. After
centrifugation, the supernatants were collected, refrigerated, and
then dried to powder using Freeze Dryer (Eyela, Tokyo, Japan). The
powder was stored at 701C until analysis.
Isolation and culture of HPMCs
Human peritoneal mesothelial cells obtained from the omental
tissue of consenting patients undergoing abdominal surgery were
isolated and characterized as described previously.55 The identity of
HPMCs was confirmed by their uniform cobblestone appearance at
confluence; presence of surface microvilli; absence of factor VIII-
related antigen staining; and presence of cytokeratin and vimentin.
All experiments were performed with confluent HPMCs from the
second passage. All cells were washed and growth arrested for 48 h in
serum-free, hydrocortisone-free culture medium prior to use.
T-lymphocyte preparation
Mononuclear cells were obtained from citrated venous blood
obtained from healthy human donors using dextran sedimentation
and Ficoll-Hypaque (Sigma-Aldrich Inc., St Louis, MO, USA)
density gradient centrifugation. To remove phagocytes, the mono-
nuclear cells were incubated on a Petri dish for 60 min at 371C.
Lymphocytes were obtained from the non-adherent fraction. The
lymphocytes were separated into T and B cells based on the
formation of E-rosettes and differential centrifugation of rosetting
and non-rosetting cells, as described previously.56
HPMC–T-cell adhesion
Sterile coverslides placed in six-well plates were prepared. A total of
1–2 105 HPMCs suspended in culture medium were added to each
well and incubated at 5% CO2, 371C for 60 min, for attachment to
occur. Then, HPMCs were stimulated with (1) Escherichia coli
0111:B4 LPS (10 mg/ml; Chemicon, Temecula, CA, USA), (2) rapid-
response PDE (1000 mg/ml), (3) delayed-response PDE (1000mg/
ml), or (4) no stimulation for 30 min at 5% CO2, 371C incubation.
For T-lymphocyte adhesion, 2 105 T lymphocytes were added to
each well and incubated for 60 min at 5% CO2 at 371C. The slides
were washed gently with phosphate-buffered saline three times to
remove non-adherent cells, followed by Liu staining. The slides were
mounted and examined under an Olympus microscope. The
percentage of HPMC–T-cell rosette formation was determined.
Rosette formation was defined as X2.5 lymphocytes attached to
each mesothelial cell. Approximately 200 HPMCs were counted
blindly in each experiment; the same observer assessed all slides.
Evaluation of integrin expression by immunofluorescence
HPMC–T-cell adhesion was stimulated and achieved under four
conditions, as described above. For immunofluorescence staining,
anti-a6b1 antibody (5A; Chemicon) or anti-a4 antibody (AB1924;
Chemicon) in a 1:50 dilution was added and the slides were
incubated for 45 min at room temperature. The slides were washed
three times in phosphate-buffered saline, and then fluorescein
isothiocyanate-labeled donkey anti-mouse IgG (AP192F; Chemicon)
or rhodamine-labeled donkey anti-rabbit IgG (AP182R; Chemicon)
at 1:200 was added. After 60 min, the slides were washed again
and mounted with buffered glycerol. The proportion of green-
fluorescing a6b1þ T cells and the proportion of red-fluorescing
a4þ T cells could be determined. These proportions were quantified
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by counting multiple high-powered fields using an Olympus
fluorescence microscope with epi-illumination and appropriate
barrier filters for fluorescein isothiocyanate and rhodamine.
Approximately 200 T cells were counted blindly in each experiment;
the same observer assessed all slides.
Generation of polarized human Th lymphocytes
Polarized Th cell lines were generated by stimulation with 2 mg/ml
phytohemagglutinin in the presence of various combinations
of cytokines and neutralizing anti-cytokine antibodies.40,41,57
Briefly, 5 ng/ml IL-12 (R&D Systems, Minneapolis, MN, USA) and
200 ng/ml neutralizing anti-IL-4 antibody (R&D Systems) were
added to the Th1 cell cultures. A 10 ng/ml quantity of IL-4 (R&D
Systems) and 2 mg/ml neutralizing anti-IL-12 antibodies (R&D
Systems) were added to the Th2 cell cultures. The cells were washed
and expanded in complete medium with 100 U/ml IL-2 (R&D
Systems) after 72 h. The T cells were harvested after 10 days of
culture, centrifuged to remove dead cells, and used immediately.
The phenotype of the differentiated T cells was confirmed by
intracellular cytokine staining.41,57 The permeabilized cells were
double-stained with fluorescein isothiocyanate-labeled anti-inter-
feron-g (R&D Systems) and phycoerythrin-labeled anti-IL-4 anti-
bodies (R&D Systems). Samples were analyzed using flow cytometry
with a FACScan (Becton Dickinson, Mountain View, CA, USA).
Establishment of a HPMC monolayer on tissue
culture inserts
To assess T-lymphocyte migration, confluent HPMCs were sub-
cultured and seeded onto the bottom side of polycarbonate tissue
culture inserts (5mm pore size, diameter 6.5 mm; Corning Costar,
Cambridge, MA, USA). The HPMC monolayers were established as
previously described.11,23 Briefly, the tissue culture inserts coated
with human type IV collagen (Sigma-Aldrich Inc.) on the upper
surface of the inverted insert were kept for 1 h at room temperature.
Then, neutralized rat tail collagen I plugs were set in the inner
chamber of the upright insert. HPMCs (5 105 cells/ml, 200 ml)
in serum-free culture medium were added to the upper (collagen
IV-coated) surface of the inverted insert and allowed to attach for
4 h at 371C. Then, the inserts were placed upright in 24-well plates
containing 1 ml of medium supplemented with 10% (vol/vol) fetal
calf serum; 0.4 ml of serum-free medium was added to the inner
chamber of the insert. The medium was replaced daily, and a
confluent monolayer was obtained after 5–10 days. Once the
monolayer reached confluence, a 48 h growth arrest period in
serum-free medium was maintained prior to the experiments.
T-lymphocyte/subset migration experiments
Collagen I plugs were removed from the growth-arrested HPMC
insert cultures before the experiments. The HPMC insert cultures
were washed with serum-free medium apically and basolaterally to
remove constitutively secreted cytokines. Then, HPMCs were
apically pre-incubated with (1) Escherichia coli 0111:B4 LPS
(10mg/ml; Chemicon), (2) rapid-response PDE (1000mg/ml), (3)
delayed-response PDE (1000mg/ml), or (4) no stimulation for 2, 6,
12, 18, 24 h prior to the addition of T lymphocytes, Th1, or Th2
cells. T lymphocytes, Th1, or Th2 cells were washed and suspended
in RPMI 1640 (Gibco, Carlsbad, CA, USA) with 0.5% bovine serum
albumin; 0.1 ml of cell suspension (1–2 106 cells) was added to
the upper chamber. T-lymphocyte migration experiments were
performed over a 6 h period at 371C with 5% CO2.
Antibody-blocking experiments
To determine the inhibitory effects that integrin-blocking antibodies
had on the migration of T lymphocytes and T-lymphocyte subsets
across HPMCs, blocking experiments were performed. T lympho-
cytes, Th1, and Th2 cell suspensions were incubated for 15 min with
anti-a6b1 blocking antibody (1:50 dilution; 5A; Chemicon) or anti-
a4 blocking antibody (1:50 dilution; P1H4; Chemicon) before the
cells were added to the upper chamber. At the 24 h time point,
the experiments included isotype-matched control monoclonal
antibodies.
Quantitation of migrated T lymphocytes and subsets
The migration of T lymphocytes and subsets across HPMCs was
assessed in the suspension isolated from the lower chamber. The
number of transmigrated cells relative to the input was measured
using flow cytometry with a FACScan (Becton Dickinson) based on
a 60 s acquisition at a flow rate of 100 ml/min.
Statistics
All data are presented as mean±s.d. Differences between groups
were analyzed by the Mann–Whitney U-test. Values of Po0.05 were
considered to be statistically significant different.
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